Effector Therapeutics Inc (EFTR) — Tangible Net Worth Ratio
Effector Therapeutics Inc (EFTR) has a Tangible Net Worth Ratio of 100.0% as of March 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($827.00K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital position of Effector Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Effector Therapeutics Inc Tangible Net Worth Ratio (2021–2022)
This chart shows how Effector Therapeutics Inc's Tangible Net Worth Ratio has changed across 2 annual periods from 2021 to 2022. As of March 2024, the ratio stands at 100.0%, reflecting net assets of $827.00K with intangible assets of $0.00 USD. See Effector Therapeutics Inc (EFTR) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Effector Therapeutics Inc (2021–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Effector Therapeutics Inc from 2021 to 2022, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Effector Therapeutics Inc worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $3.90 Million | $0.00 | $29.08 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $17.28 Million | $0.00 | $54.06 Million | — |